INFLAMOSTAT Trademark
Serial Number: 98436739
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Constance B. Stefanou Morgan, Lewis & Bockius LLP
1111 Pennsylvania Avenue, NW
Attn: TMSU
Washington, DC 20004
United States
Trademark Details
Filing Date
March 6, 2024
Registration Date
Not Registered
Published for Opposition
December 31, 2024
Goods & Services
Synthetic and collagen peptides for use in the fields of medical diagnostics and biotechnology, namely, for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; pharmaceutical preparations for use in the fields of medical diagnostics and biotechnology, namely, topical drugs for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides for pharmaceutical purposes for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides for the treatment of various conditions and diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; synthetic and collagen peptides sold as ingredient in pharmaceutical preparations for the treatment immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; pharmaceutical preparations containing synthetic and collagen peptides for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases; chemical preparations for sanitary use, namely, for coating medical devices, and for wound dressings; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; injectable pharmaceuticals for the treatment of immune mediated diseases, namely, dermal, eye, systemic, inflammatory, autoimmune, rheumatic, liver, and gastrointestinal conditions and diseases;
Cosmetics; ingredient complex composed of synthetic and collagen peptides sold as an integral component of cosmetic preparations;